FDA advisers back XBB-targeted COVID shots for 2023-24 campaign

Advisers to the U.S. Food and Drug
Administration on Thursday unanimously backed the use of updated
COVID-19 vaccines that would target an XBB Omicron subvariant of
the coronavirus for the 2023-2024... | June 15, 2023

Related Keywords

New York ,United States ,Bengaluru ,Karnataka ,India ,Sriparna Roy ,Bhanvi Satija ,Drug Administration On ,Reuters ,Drug Administration ,Michael Erman ,Bill Berkrot ,Pfizer ,Nc Stock Exchange ,News ,Information ,Press Release ,Advisers ,O ,The ,Wood ,End ,N ,Hursday ,Nunanimously ,Backed ,Tse ,F ,Vaccines ,Hat ,Would ,Target ,Ibb ,Micron ,Ubvariant ,Coronavirus ,Or ,He Pfe Us7170811035 ,